Large‐Scale Protein Assay Identifies Novel Protein Biomarkers Associated With Arterial Stiffness and Vascular Calcification Measures
International Journal of Hypertension · 2026-01 · 2026 (1)
DOI: 10.1155/ijhy/9724102 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Hypertension, online erschienen am 14.07.2026. Verfasst von Rain Katz und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, University of Pittsburgh School of Public Health, 130 De Soto St, Pittsburgh, 15261, Pennsylvania, USA, ufl.edu. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Large‐scale protein assays have the potential to identify novel biomarkers and improve prediction of cardiovascular disease (CVD) risk. The burden of atherosclerotic CVD and related risk factors is disproportionately high in Afro‐Caribbean populations in whom novel risk prediction strategies may be warranted. Thus, we analyzed the association of early atherosclerosis markers with peripheral blood proteomic biomarkers quantified using the Olink Target 96 Cardiovascular III panel in 342 community‐dwelling men from the Tobago Health Study. Atherosclerosis markers included pulse wave velocity (PWV), abdominal aortic calcification (AAC), and coronary artery calcification (CAC). Blood pressure, height, and weight were measured by trained clinic staff. Hypertension, dyslipidemia, and diabetes status were classified via clinical measures and the prescription of relevant medication. Statistical methods included differential expression analysis fully adjusted for assay batch, age, BMI, smoking, diabetes, dyslipidemia, and blood pressures. Men ranged from 53 to 89 years of age (mean ± SD = 63.3 ± 8.1 years). Average BMI was 27.7 ± 4.3 kg/m 2 , 79.2% had hypertension, average LDL cholesterol was 129.4 ± 37.7 mg/dL, 24.6% had diabetes, and 5.9% were current smokers. In fully adjusted models, 18 proteins were associated with PWV and 1 was associated with CAC. There were no significant associations with AAC. Thirteen of these significant associations (12 PWV and 1 CAC) were novel, having never been identified as associated with these atherosclerosis measures in any previous study. While these proteins are involved in physiological processes known to contribute to CVD, such as inflammation, the strongest effects were seen for previously unreported protein associations. Our work is the first large‐scale protein assay performed in an Afro‐Caribbean population and adds to existing evidence that indicates that protein biomarker signatures of CVD may differ by racial/ethnic group. Further research is needed to understand the role of protein biomarkers in the prediction and progression of CVD among this high‐risk group.
Autor:innen und Institutionen
- Department of Epidemiology, University of Pittsburgh School of Public Health, 130 De Soto St, Pittsburgh, 15261, Pennsylvania, USA, ufl.edu.
- Department of Biostatistics, University of Pittsburgh School of Public Heatlth, 130 De Soto St, Pittsburgh, 15261, Pennsylvania, USA.
- Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, 420 Delaware Street SE, Minneapolis, 55455, Minneapolis, USA, umn.edu.
- Division of Cardiovascular Medicine, Vanderbilt University Medical Center, 1161 21st Ave S, Nashville, Tennessee, 37232, USA, vanderbilt.edu.
- Department of Environmental and Occupational Health, University of Pittsburgh School of Public Health, 130 De Soto St, Pittsburgh, 15261, Pennsylvania, USA.
- Departments of Medicine, and Epidemiology and Biostatistics, Michigan State University, 15 Michigan St NE, Grand Rapids, Michigan, 49503, USA, msu.edu.
ORCID-Profile: Rain Katz, Ryan Cvejkus, Jiebiao Wang, Bharat Thyagarajan, Emma Barinas-Mitchell, John Jeffrey Carr, James G Terry, Winnie Wan-Yee Tang, Rachel G Miller, Iva Miljkovic, Joseph M Zmuda, Allison L Kuipers
Förderung
- NHLBI NIH HHS
- NIDDK NIH HHS
- National Heart, Lung, and Blood Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Katz, R., Cvejkus, R., Wang, J., Thyagarajan, B., Barinas-Mitchell, E., Carr, J. J., Terry, J. G., Nair, S., Tang, W. W., Miller, R. G., Miljkovic, I., Zmuda, J. M., & Kuipers, A. L. (2026). Large‐Scale Protein Assay Identifies Novel Protein Biomarkers Associated With Arterial Stiffness and Vascular Calcification Measures. International Journal of Hypertension, 2026(1). https://doi.org/10.1155/ijhy/9724102
Vancouver
Katz R, Cvejkus R, Wang J, Thyagarajan B, Barinas-Mitchell E, Carr JJ, et al. Large‐Scale Protein Assay Identifies Novel Protein Biomarkers Associated With Arterial Stiffness and Vascular Calcification Measures. International Journal of Hypertension. 2026;2026(1). doi:10.1155/ijhy/9724102
BibTeX
@article{Katz2026,
author = {Katz, Rain and Cvejkus, Ryan and Wang, Jiebiao and Thyagarajan, Bharat and Barinas-Mitchell, Emma and Carr, John Jeffrey and Terry, James G and Nair, Sangeeta and Tang, Winnie Wan-Yee and Miller, Rachel G and Miljkovic, Iva and Zmuda, Joseph M and Kuipers, Allison L},
title = {Large‐Scale Protein Assay Identifies Novel Protein Biomarkers Associated With Arterial Stiffness and Vascular Calcification Measures},
journal = {International Journal of Hypertension},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ijhy/9724102}
}
EUVIMED